Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
To be clear, this isnt necessarily a craven act of greed on the part of these providers, it could also be a testament to the power of confirmation bias, or a tacit acknowledgment that there is some limit to their willingness to put higher-weight peoples lives and quality of life at risk and compounding the meds is a bridge too far for them
There was no statistically significant difference between the tirzepatide group and the control group for risk of cholelithiasis (RR 1.19 [95%CI] [0.55, 2.58], P =.66, I 2 =0%)
Determination of carnitine and saturated-acyl group carnitines in human urine by high-performance liquid chromatography with fluorescence detection
In addition, the absence of the P53 tumor suppressor gene can obstruct Gln utilization by decreasing GLS2 levels inside cells and boosting ROS levels (68)
doi: 10.1002/14651858.CD005228.pub2